06:46 AM EDT, 07/02/2024 (MT Newswires) -- Blackstone (BX) is close to a deal to sell Japanese supplement maker Alinamin Pharmaceutical to MBK Partners for 350 billion yen ($2.17 billion), Reuters reported Tuesday, citing a person with knowledge of the matter.

Alinamin is a Japanese provider of over-the-counter medicines, with a unit in Taiwan.

Blackstone, MBK Partners, and Alinamin did not reply to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 121.70, Change: -0.53, Percent Change: -0.43